What does CUSIP 29251M106 represent in this 13F holders report?

CUSIP 29251M106 is the security identifier for ENTA - ENANTA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in Q1 2021?

146 institutional investors reported ENTA - ENANTA PHARMACEUTICALS INC - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 28,862,345
Total 13F shares: 19,430,818
Share change: +73,962
Total reported value: $956,710,887
Put/Call ratio: 271%
Price per share: $49.32
Number of holders: 146
Value change: +$7,403,943
Number of buys: 65
Number of sells: 72

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 29251M106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	12%	3,406,000	$143,393,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	6.2%	1,800,579	$75,804,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	6.1%	1,775,000	$74,728,000	—	31 Dec 2020	13F
ARMISTICE CAPITAL, LLC	13F	Company	4.7%	1,356,000	$57,088,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	4.1%	1,173,240	$49,393,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.6%	1,033,900	$43,527,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.3%	961,445	$40,477,000	—	31 Dec 2020	13F
Krensavage Asset Management, LLC	13F	Company	3%	858,811	$36,156,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.3%	671,221	$28,258,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	2%	563,211	$23,711,000	—	31 Dec 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.6%	467,514	$19,684,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.99%	285,580	$12,022,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.86%	248,320	$10,454,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.82%	237,729	$10,009,000	—	31 Dec 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.82%	237,679	$10,006,000	—	31 Dec 2020	13F
Granahan Investment Management, LLC	13F	Company	0.8%	231,071	$9,728,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.67%	193,094	$8,129,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.62%	178,941	$7,534,000	—	31 Dec 2020	13F
Man Group plc	13F	Company	0.61%	177,288	$7,464,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.61%	176,769	$7,442,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	161,414	$6,795,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.55%	158,156	$6,658,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.53%	154,002	$6,483,000	—	31 Dec 2020	13F
Fairmount Funds Management LLC	13F	Company	0.52%	150,433	$6,333,000	—	31 Dec 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.44%	127,080	$5,350,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.42%	120,732	$5,083,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.38%	110,992	$4,673,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.36%	103,492	$4,342,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.31%	90,800	$3,823,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.3%	87,929	$3,702,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.3%	87,473	$3,683,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.24%	69,625	$2,931,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.23%	66,004	$2,779,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.23%	65,257	$2,747,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.23%	65,239	$2,747,000	—	31 Dec 2020	13F
Hudson Bay Capital Management LP	13F	Company	0.22%	64,600	$2,720,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.2%	57,940	$2,439,000	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0.18%	51,537	$2,169,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.18%	50,606	$2,131,000	—	31 Dec 2020	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.17%	50,052	$2,107,000	—	31 Dec 2020	13F
SG Americas Securities, LLC	13F	Company	0.16%	45,663	$1,922,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.15%	44,253	$1,863,000	—	31 Dec 2020	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.15%	44,086	$1,856,000	—	31 Dec 2020	13F
York State Teachers Retirement System New	13F	Individual	0.15%	43,583	$1,835,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.15%	42,395	$1,785,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.15%	42,243	$1,779,000	—	31 Dec 2020	13F
PUBLIC SECTOR PENSION INVESTMENT BOARD	13F	Company	0.14%	39,552	$1,665,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.13%	38,500	$1,621,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.13%	37,898	$1,596,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.13%	37,837	$1,594,000	—	31 Dec 2020	13F

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q1 2021

As of 31 Mar 2021, ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) was held by 146 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,430,818 shares. The largest 10 holders included BlackRock Inc., Farallon Capital Management, L.L.C., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, Krensavage Asset Management, LLC, NORTHERN TRUST CORP, and DIMENSIONAL FUND ADVISORS LP. This page lists 146 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

148

Q1 2021 holders

146

Holder diff

-2

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.